
New mRNA Flu Vaccine Being Considered for Fall Use
In February, FDA announced that it would not review Moderna’s mRNA influenza vaccine; reversed its position about a week later; and now has agreed
we are committed to delivering innovative solutions that drive growth and add value to our clients. With a team of experienced professionals and a passion for excellence.

In February, FDA announced that it would not review Moderna’s mRNA influenza vaccine; reversed its position about a week later; and now has agreed

Traceability is a very important tool for public health officials when trying to understand where food may have been contaminated. Yet we have learned

Good news for Canadian consumers: Canada’s food industry is achieving “very high rates of compliance” in food safety according to the CFIA. CFIA’s most

Although raw milk accounts for less than 3% of U.S. milk sales, it is associated with 840 times more illnesses and 45 times more

Although new WHO findings show that the US has a relatively low disease burden compared to the rest of the world, the economic impact

On June 8, the USDA confirmed additional cases of New World screwworm (NWS) in Texas, all in counties near the Mexican border. The first

Safe food is always the ultimate goal, but is zero risk actually achievable? To better discuss this, let’s start with an example of a

A tick control pilot program, innovation challenges, focused NIH funding, and a public-private collaboration are all part of the HHS’ new multi-million-dollar initiative to

Although FDA is actively expanding its use of artificial intelligence with agentic AI systems “designed to achieve specific goals by planning, reasoning, and executing multi-step actions,” the agency is
© 2026 The Acheson Group. All rights reserved